$RNAC
Cartesian Therapeutics, Inc.

2022 Q3 Form 10-Q Financial Statement

#000145368722000125 Filed on August 08, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $20.71M $39.27M $34.00M
YoY Change -15.22% 99.73% 207.68%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.770M $6.231M $5.537M
YoY Change 5.97% 31.23% 6.48%
% of Gross Profit
Research & Development $16.54M $19.18M $17.69M
YoY Change -21.06% 32.63% 36.03%
% of Gross Profit
Depreciation & Amortization $200.0K $200.0K $100.0K
YoY Change 100.0% 0.0% 0.0%
% of Gross Profit
Operating Expenses $22.31M $25.41M $23.23M
YoY Change -15.48% 32.28% 27.56%
Operating Profit -$1.599M $13.86M $10.77M
YoY Change -18.79% 2966.37% -250.5%
Interest Expense $802.0K $715.0K $707.0K
YoY Change 12.8% 0.56% -0.56%
% of Operating Profit 5.16% 6.56%
Other Income/Expense, Net $1.000K $0.00 $154.0K
YoY Change -88.89% -100.0%
Pretax Income -$8.214M $8.601M $28.78M
YoY Change 297.58% 88.41% -216.98%
Income Tax -$321.0K
% Of Pretax Income
Net Earnings -$7.893M $8.601M $28.78M
YoY Change -55.89% 88.41% -217.0%
Net Earnings / Revenue -38.11% 21.9% 84.64%
Basic Earnings Per Share -$0.05 $0.06 $0.23
Diluted Earnings Per Share -$0.05 $0.06 $0.08
COMMON SHARES
Basic Shares Outstanding 152.7M shares 148.5M shares 124.2M shares
Diluted Shares Outstanding 152.8M shares 148.5M shares 127.6M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $146.4M $142.1M $117.4M
YoY Change 5.61% -5.38% -20.55%
Cash & Equivalents $112.8M $138.1M $113.4M
Short-Term Investments $33.60M $3.999M $3.997M
Other Short-Term Assets $6.310M $6.522M $5.420M
YoY Change 9.15% -20.56% -22.57%
Inventory
Prepaid Expenses
Receivables $6.925M $23.99M $7.153M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $159.7M $172.6M $130.0M
YoY Change 5.21% 3.45% -20.3%
LONG-TERM ASSETS
Property, Plant & Equipment $2.904M $2.833M $2.689M
YoY Change 60.71% 59.34% 106.69%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.000M $2.000M $2.000M
YoY Change 0.0%
Other Assets $1.628M $1.425M $1.464M
YoY Change 10.75% -7.05% -8.5%
Total Long-Term Assets $18.59M $15.50M $15.69M
YoY Change 20.75% 13.03% 15.18%
TOTAL ASSETS
Total Short-Term Assets $159.7M $172.6M $130.0M
Total Long-Term Assets $18.59M $15.50M $15.69M
Total Assets $178.3M $188.1M $145.7M
YoY Change 6.64% 4.18% -17.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $214.0K $693.0K $264.0K
YoY Change -86.57% 350.0% -55.56%
Accrued Expenses $12.26M $12.37M $8.889M
YoY Change 14.16% 39.56% 29.82%
Deferred Revenue $3.820M $15.97M $27.99M
YoY Change -93.87% -78.71% -63.06%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $5.879M $3.285M $696.0K
YoY Change 42.52% 43.39% 39.2%
Total Short-Term Liabilities $23.73M $33.76M $39.25M
YoY Change -75.18% -61.32% -53.61%
LONG-TERM LIABILITIES
Long-Term Debt $20.22M $22.63M $25.04M
YoY Change -5.11% -1.3% 1.8%
Other Long-Term Liabilities $49.42M $42.07M $25.64M
YoY Change -28.36% -43.55% -70.59%
Total Long-Term Liabilities $69.63M $64.70M $50.69M
YoY Change -22.87% -33.61% -54.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $23.73M $33.76M $39.25M
Total Long-Term Liabilities $69.63M $64.70M $50.69M
Total Liabilities $93.36M $98.46M $89.93M
YoY Change -49.78% -46.7% -54.19%
SHAREHOLDERS EQUITY
Retained Earnings -$400.8M -$392.9M -$401.5M
YoY Change -9.44% -7.48% -6.45%
Common Stock $15.00K $15.00K $12.00K
YoY Change 25.0% 25.0% 9.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $84.91M $89.61M $55.76M
YoY Change
Total Liabilities & Shareholders Equity $178.3M $188.1M $145.7M
YoY Change 6.64% 4.18% -17.57%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$7.893M $8.601M $28.78M
YoY Change -55.89% 88.41% -217.0%
Depreciation, Depletion And Amortization $200.0K $200.0K $100.0K
YoY Change 100.0% 0.0% 0.0%
Cash From Operating Activities $4.353M -$12.27M -$11.86M
YoY Change -140.51% 102.96% -2.22%
INVESTING ACTIVITIES
Capital Expenditures -$436.0K -$99.00K $455.0K
YoY Change 165.85% -83.85% 1720.0%
Acquisitions
YoY Change
Other Investing Activities -$29.50M $0.00 $10.00M
YoY Change 1701.04% -100.0% -144.6%
Cash From Investing Activities -$29.94M -$99.00K $9.545M
YoY Change 1561.32% -96.21% -142.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.690M
YoY Change -91.95%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 612.0K 36.88M $1.728M
YoY Change -57.79% 310.59% -91.89%
NET CHANGE
Cash From Operating Activities 4.353M -12.27M -$11.86M
Cash From Investing Activities -29.94M -99.00K $9.545M
Cash From Financing Activities 612.0K 36.88M $1.728M
Net Change In Cash -24.97M 24.51M -$620.0K
YoY Change 125.01% 7440.0% -95.33%
FREE CASH FLOW
Cash From Operating Activities $4.353M -$12.27M -$11.86M
Capital Expenditures -$436.0K -$99.00K $455.0K
Free Cash Flow $4.789M -$12.17M -$12.32M
YoY Change -145.26% 124.04% 1.32%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001453687
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37798
dei Entity Registrant Name
EntityRegistrantName
Selecta Biosciences, Inc
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1622110
dei Entity Address Address Line1
EntityAddressAddressLine1
65 Grove Street,
dei Entity Address City Or Town
EntityAddressCityOrTown
Watertown,
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02472
dei City Area Code
CityAreaCode
617
dei Local Phone Number
LocalPhoneNumber
923-1400
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
SELB
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
152713211 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
138057000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
114057000 usd
CY2022Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
3999000 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
13998000 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
23994000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9914000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6522000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6474000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
172572000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
144443000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2833000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2142000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9238000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9829000 usd
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1379000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1379000 usd
CY2022Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
2000000 usd
CY2021Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
2000000 usd
CY2022Q2 us-gaap Other Assets
OtherAssets
46000 usd
CY2021Q4 us-gaap Other Assets
OtherAssets
90000 usd
CY2022Q2 us-gaap Assets
Assets
188068000 usd
CY2021Q4 us-gaap Assets
Assets
159883000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
693000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
224000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12366000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10533000 usd
CY2022Q2 us-gaap Loans Payable Current
LoansPayableCurrent
3285000 usd
CY2021Q4 us-gaap Loans Payable Current
LoansPayableCurrent
5961000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1125000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1049000 usd
CY2022Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
320000 usd
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
601000 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
15974000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
53883000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
33763000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
72251000 usd
CY2022Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
22634000 usd
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
19673000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8018000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8598000 usd
CY2022Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
7113000 usd
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
11417000 usd
CY2022Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
26934000 usd
CY2021Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
25423000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
98462000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
137362000 usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
152713211 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
152713211 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
123622965 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
123622965 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
15000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
12000 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
487008000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
457391000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-392937000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-430316000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4480000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4566000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
89606000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
22521000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
39273000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
188068000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
159883000 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19663000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
73272000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
30713000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19182000 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14463000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
36871000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
27467000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6231000 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4748000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11768000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9952000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
25413000 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
19211000 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
452000 usd
us-gaap Operating Expenses
OperatingExpenses
48639000 usd
us-gaap Operating Expenses
OperatingExpenses
37419000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
13860000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
24633000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-6706000 usd
CY2022Q2 us-gaap Investment Income Net
InvestmentIncomeNet
207000 usd
CY2021Q2 us-gaap Investment Income Net
InvestmentIncomeNet
12000 usd
us-gaap Investment Income Net
InvestmentIncomeNet
222000 usd
us-gaap Investment Income Net
InvestmentIncomeNet
24000 usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-104000 usd
CY2021Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-14000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-76000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-7000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
715000 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
711000 usd
us-gaap Interest Expense
InterestExpense
1422000 usd
us-gaap Interest Expense
InterestExpense
1422000 usd
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
4647000 usd
CY2021Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4820000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-13868000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
11927000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
154000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
8601000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
4565000 usd
us-gaap Net Income Loss
NetIncomeLoss
37379000 usd
us-gaap Net Income Loss
NetIncomeLoss
-20032000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
118000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
12000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
86000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
6000 usd
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 usd
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8719000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4578000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
37465000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20026000 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
148505729 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
113524110 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
136436316 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
112140815 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
148505729 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
121177998 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
136966312 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
112140815 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
22521000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
127000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
21000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1675000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-79000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2753000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-32000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
28778000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
55764000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
21480000 usd
CY2022Q2 selb Stock Issued During Period Value New Issues Under License Agreement
StockIssuedDuringPeriodValueNewIssuesUnderLicenseAgreement
1000000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
79000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2564000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
118000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
8601000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
89606000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-18006000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
72000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
244000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
CY2021Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
20943000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1780000 usd
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6000 usd
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-24597000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-19571000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
425000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
CY2021Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
8563000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1783000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
12000 usd
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
4565000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-4222000 usd
us-gaap Net Income Loss
NetIncomeLoss
37379000 usd
us-gaap Net Income Loss
NetIncomeLoss
-20032000 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
696000 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
512000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
0 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-28000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
591000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
549000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
147000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
6317000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
3563000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
579000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
594000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-13868000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
11927000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
14080000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1241000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
374000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2811000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
300000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-289000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-280000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-42213000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-11046000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
965000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
70000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-24135000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18176000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
10000000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
0 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
0 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
24417000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
554000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
643000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
9446000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25060000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
110000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 usd
selb Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
36890000 usd
selb Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
21000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
672000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
127000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
72000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
38603000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
30291000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
86000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
24000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12936000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
115436000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
140064000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
139436000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
127128000 usd
us-gaap Interest Paid Net
InterestPaidNet
1014000 usd
us-gaap Interest Paid Net
InterestPaidNet
998000 usd
us-gaap Stock Issued1
StockIssued1
1000000 usd
us-gaap Stock Issued1
StockIssued1
0 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
320000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2000 usd
selb Equity Offering Costs In Accrued Liabilities
EquityOfferingCostsInAccruedLiabilities
31000 usd
selb Equity Offering Costs In Accrued Liabilities
EquityOfferingCostsInAccruedLiabilities
44000 usd
CY2022Q2 selb Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Debt Securities Available For Sale
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndDebtSecuritiesAvailableForSale
143400000 usd
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1400000 usd
CY2022Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
3999000 usd
CY2022Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2022Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 usd
CY2022Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3999000 usd
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
13999000 usd
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1000 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
13998000 usd
us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
8601000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
4565000 usd
us-gaap Net Income Loss
NetIncomeLoss
37379000 usd
us-gaap Net Income Loss
NetIncomeLoss
-20032000 usd
CY2021Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
4820000 usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
13868000 usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
0 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
8601000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
8601000 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-255000 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-255000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
23511000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
23511000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-20032000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-20032000 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
148505729 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
113524110 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
136436316 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
112140815 shares
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2021Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
7653888 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
529996 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
148505729 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
121177998 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
136966312 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
112140815 shares
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
47729897 shares
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10866602 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
37524598 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
22952149 shares
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
138057000 usd
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
125749000 usd
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1379000 usd
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1379000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
139436000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
127128000 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4834000 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7667000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6939000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4797000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2833000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2142000 usd
CY2022Q2 us-gaap Depreciation
Depreciation
200000 usd
us-gaap Depreciation
Depreciation
300000 usd
CY2021Q2 us-gaap Depreciation
Depreciation
200000 usd
us-gaap Depreciation
Depreciation
300000 usd
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2223000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3179000 usd
CY2022Q2 selb Accrued Collaborationand Licensing
AccruedCollaborationandLicensing
500000 usd
CY2021Q4 selb Accrued Collaborationand Licensing
AccruedCollaborationandLicensing
0 usd
CY2022Q2 selb Accrued Patent Fees Current
AccruedPatentFeesCurrent
885000 usd
CY2021Q4 selb Accrued Patent Fees Current
AccruedPatentFeesCurrent
309000 usd
CY2022Q2 selb Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
6701000 usd
CY2021Q4 selb Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
4339000 usd
CY2022Q2 selb Accrued Audit Fees Current
AccruedAuditFeesCurrent
547000 usd
CY2021Q4 selb Accrued Audit Fees Current
AccruedAuditFeesCurrent
815000 usd
CY2022Q2 selb Accrued Interest Current
AccruedInterestCurrent
184000 usd
CY2021Q4 selb Accrued Interest Current
AccruedInterestCurrent
170000 usd
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1326000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1721000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12366000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10533000 usd
CY2021Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
900000 usd
CY2022Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
900000 usd
us-gaap Loss Contingency Claims Settled Number
LossContingencyClaimsSettledNumber
2 lawsuit
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
505000 usd
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
454000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
1011000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
898000 usd
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
205000 usd
CY2021Q2 us-gaap Variable Lease Cost
VariableLeaseCost
182000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
425000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
470000 usd
CY2022Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
2000 usd
CY2021Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
2000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
5000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
5000 usd
CY2022Q2 us-gaap Lease Cost
LeaseCost
712000 usd
CY2021Q2 us-gaap Lease Cost
LeaseCost
638000 usd
us-gaap Lease Cost
LeaseCost
1441000 usd
us-gaap Lease Cost
LeaseCost
1373000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
942000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1922000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1980000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2039000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2101000 usd
CY2022Q2 selb Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
2844000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
11828000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2685000 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
9143000 usd
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
us-gaap Operating Lease Payments
OperatingLeasePayments
924000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
898000 usd
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y10M24D
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y10M24D
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.089
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.089
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000 shares
selb Stock Issued During Period Shares Warrants Issued
StockIssuedDuringPeriodSharesWarrantsIssued
20571429 shares
selb Stock Issued During Period Shares Warrants Exercised
StockIssuedDuringPeriodSharesWarrantsExercised
0 shares
selb Stock Issued During Period Shares Warrants Canceled
StockIssuedDuringPeriodSharesWarrantsCanceled
79130 shares
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10735980 shares
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.62
selb Stock Issued During Period Shares Warrants Issued
StockIssuedDuringPeriodSharesWarrantsIssued
20571429 shares
us-gaap Warrant Exercise Price Increase
WarrantExercisePriceIncrease
1.55
selb Stock Issued During Period Shares Warrants Canceled
StockIssuedDuringPeriodSharesWarrantsCanceled
79130 shares
selb Warrant Exercise Price Canceled
WarrantExercisePriceCanceled
17.71
CY2022Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
31228279 shares
CY2022Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.53
CY2022Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
54692176 shares
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
28209867 shares
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3564000 usd
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1783000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6317000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3563000 usd
CY2022Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
23100000 usd
CY2021Q4 selb Contractwith Customer Liability Deferred Revenue
ContractwithCustomerLiabilityDeferredRevenue
65300000 usd
selb Contractwith Customer Liability Deferred Revenue Increase From Cash Receipts
ContractwithCustomerLiabilityDeferredRevenueIncreaseFromCashReceipts
16000000 usd
selb Contractwith Customer Liability Deferred Revenue Revenue Recognized
ContractwithCustomerLiabilityDeferredRevenueRevenueRecognized
58213000 usd
CY2022Q2 selb Contractwith Customer Liability Deferred Revenue
ContractwithCustomerLiabilityDeferredRevenue
23087000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
65300000 usd
selb Contractwith Customer Liability Increase From Cash Receipts
ContractwithCustomerLiabilityIncreaseFromCashReceipts
16000000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
58213000 usd
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
23087000 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
51100000 usd
selb Defined Contribution Plan Employers Matching Contribution Vesting Period
DefinedContributionPlanEmployersMatchingContributionVestingPeriod
P2Y
CY2021Q2 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
100000 usd
CY2022Q2 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
100000 usd
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
200000 usd
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
100000 usd
CY2022Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
900000 usd

Files In Submission

Name View Source Status
0001453687-22-000125-index-headers.html Edgar Link pending
0001453687-22-000125-index.html Edgar Link pending
0001453687-22-000125.txt Edgar Link pending
0001453687-22-000125-xbrl.zip Edgar Link pending
exhibit311_06302022.htm Edgar Link pending
exhibit312_06302022.htm Edgar Link pending
exhibit321_06302022.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
selb-20220630.htm Edgar Link pending
selb-20220630.xsd Edgar Link pending
Show.js Edgar Link pending
selb-20220630_def.xml Edgar Link unprocessable
selb-20220630_pre.xml Edgar Link unprocessable
selb-20220630_htm.xml Edgar Link completed
selb-20220630_lab.xml Edgar Link unprocessable
selb-20220630_cal.xml Edgar Link unprocessable